Correlation Between Cannabix Technologies and Accelerate Diagnostics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cannabix Technologies and Accelerate Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannabix Technologies and Accelerate Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cannabix Technologies and Accelerate Diagnostics, you can compare the effects of market volatilities on Cannabix Technologies and Accelerate Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannabix Technologies with a short position of Accelerate Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannabix Technologies and Accelerate Diagnostics.

Diversification Opportunities for Cannabix Technologies and Accelerate Diagnostics

-0.18
  Correlation Coefficient

Good diversification

The 3 months correlation between Cannabix and Accelerate is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Cannabix Technologies and Accelerate Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Accelerate Diagnostics and Cannabix Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannabix Technologies are associated (or correlated) with Accelerate Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Accelerate Diagnostics has no effect on the direction of Cannabix Technologies i.e., Cannabix Technologies and Accelerate Diagnostics go up and down completely randomly.

Pair Corralation between Cannabix Technologies and Accelerate Diagnostics

Assuming the 90 days horizon Cannabix Technologies is expected to generate 1.03 times more return on investment than Accelerate Diagnostics. However, Cannabix Technologies is 1.03 times more volatile than Accelerate Diagnostics. It trades about 0.02 of its potential returns per unit of risk. Accelerate Diagnostics is currently generating about -0.02 per unit of risk. If you would invest  38.00  in Cannabix Technologies on August 28, 2024 and sell it today you would lose (11.00) from holding Cannabix Technologies or give up 28.95% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Cannabix Technologies  vs.  Accelerate Diagnostics

 Performance 
       Timeline  
Cannabix Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cannabix Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Accelerate Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Accelerate Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Cannabix Technologies and Accelerate Diagnostics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cannabix Technologies and Accelerate Diagnostics

The main advantage of trading using opposite Cannabix Technologies and Accelerate Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannabix Technologies position performs unexpectedly, Accelerate Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Accelerate Diagnostics will offset losses from the drop in Accelerate Diagnostics' long position.
The idea behind Cannabix Technologies and Accelerate Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Commodity Directory
Find actively traded commodities issued by global exchanges